We are thrilled to welcome Prof. Steve Oh as our Scientific Advisor. With his extensive knowledge and experience in stem cell bioprocessing, including microcarrier cultures, bioreactor expansion, hESC cultures on engineered surfaces, differentiation of hESC-derived cardiomyocytes, and imaging and monitoring of pluripotent stem cells, Steve brings a wealth of expertise to our team.
Steve Oh’s vast experience in bioprocessing and purification, including the creation of scalable serum-free media, attests to his exceptional knowledge and skill in the field. With a proven history of effectively leading a team of 30 and managing substantial grants worth $25 million, Steve’s impact on the industry is undeniable, as evidenced by his 135 published papers, 43 patents, numerous industry collaborations, and popular keynote presentations numbering over 230. Additionally, his 11978 citations on Google Scholar further illustrate the magnitude of his contributions to the field of cell and gene therapy manufacturing, where he also serves as a respected reviewer for national research programs.
We are confident that Steve’s expertise and achievements will make a valuable contribution to our company and we are excited to have him on board. Welcome, Steve!”